International Society for antiviral research
Schedule-at-a-glanceThe 2019 ICAR will begin on Sunday, May 12, 2019, and will conclude on Wednesday, May 15, 2019. The confirmed invited speakers are listed below as well as their talk titles. Click here to view the speakers' bios. The 2019 ICAR Schedule-at-a-Glance will be posted shortly. Invited Speakers & Talk Titles New antivirals for chronic hepatitis BTimothy Block In search of novel antivirals using structure-based drug design approaches Andrea Brancale Therapeutic strategies to combat cytomegalovirus infection Rhonda Cardin Effects of Broadly Neutralizing Antibody Combinations in HIV-1 Infection Marina Caskey Polio eradication: need for antivirals and progress to date Marc S. Collett CRISPR/Cas targeting and inactivation of viral DNA genomes Bryan R. Cullen Human retroviruses (HTLV-1 and HIV): Current therapy and prevention Robert Gallo Long-acting, slow effective release antiretroviral therapy Howard Gentleman Small molecules for big problems in large animals Nesya Goris Measles: a role for virus persistence? Diane Griffin Development of medical countermeasures against Nipah virus: A field perspective Emily Gurley
Update on influenza polymerase inhibitors Frederick Hayden A universal influenza virus vaccine based on the conserved stalk of the hemagglutinin Florian Krammer Remdesivir (GS-5734), a broad-spectrum antiviral agent Richard Mackman Preparing for the worst: research on antiviral compounds against smallpox Victoria Olson Antivirals against chikungunya virus from a medchem perspective: challenges and lessons learned María-Jesús Pérez-Pérez The advancement of HIV NRTTIs for extended-duration dosing: a medicinal chemistry case study Izzat Raheem Research for preparedness for arboviruses and hemorrhagic fever viruses in subsaharan Africa Amadou Sall A retrospective of rational (and sometimes irrational!) nucleoside design modifications Kathie Seley-Radtke 101 years of influenza: Lessons from the 1918 pandemic Jeffery Taubenberger Having an impact: Implementing WHO’s global program on MERS Maria Van Kerkhove Antivirals against dengue and Zika: new findings and future prospects Subhash VasudevanThe interplay between virus and host innate immunity Yan-Yi Wang Can we predict arbovirus epidemics? Scott Weaver |
About ISARThe International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians. |